Medical Research
(H129)
IRS Verified
DX Registered
990 on File
HEREDITARY NEUROPATHY FOUNDATION INC
Financial strength (30%)
77/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Please know that you will be helping millions of people worldwide who are affected by this terrible and often debilitating disease. All proceeds from the event will go to support HNF’s Therapeutic Research in Accelerated Discovery (TRIAD) program, a collaborative research program of academia, government and industry partners.
Financial Overview — FY 2023
$544K
Total Revenue
$671K
Total Expenses
$1.5M
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
85.2%
Fundraising Efficiency
N/A
Operating Reserve
26.86x
Liability-to-Asset
0.8%
Revenue Diversification
103.0%
Executive Compensation
$66K
Compared with Peers
FY 2023
Compared with 1,004 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
85.2% | 86.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.6% | 10.6% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.3% | 0.0% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
26.9 mo | 13.1 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.8% | 0.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
103.0% | 95.3% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-56.9% | 4.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-11.6% | 12.9% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-23.5% | -0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $544K | $671K | $1.5M | 85.2% | 2 |
| 2022 | $1.3M | $759K | $1.6M | 90.6% | 2 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.